Trial · NCT07878078
Influence of Art Workshops and Cognitive Support for Families of Children With Cancer.
NCT07878078, Phase 3, Recruiting, Children's Cancer Hospital Egypt 57357
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Influence of Art Workshops and Cognitive Support for Families of Children With Cancer. Trials, record NCT07878078. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07878078
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Influence of Art Workshops and Cognitive Support for Families of Children With Cancer.
- NCT number
- NCT07878078
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 64 participants, estimated
- Lead sponsor
- Children's Cancer Hospital Egypt 57357
- Conditions
- Psychologic Resilience
- Interventions
- Art Workshops and Cognitive Support Sessions.
- First posted
- 2026-10-16
- Last updated
- 2026-10-16
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Psychological Resilience Scale by Connor and Davidson (Davidson-Connor), adapted by Singh and Nan Yu (2010) and translated to Arabic by Ahmed Elbaiomy. | From enrollment to the end of the program at 3 months (total of 12 sessions) | The Connor-Davidson Resilience Scale (CD-RISC) defines resilience through several dimensions, each capturing a different psychological strength: hardiness, optimism, resourcefulness, and purpose/goal. Together, they measure how individuals adapt and thrive under stress. The scale consists of 25 items. Responses are given from the following options: * Very high degree * High degree * Moderate degree * Low degree * Very low degree Each item is scored from 5 points down to 1 point. The highest possible score is 125 (25 items × 5 points). The lowest possible score is 25 (25 items × 1 point). High scores indicate strong resilience, while low scores indicate weak resilience. |
| Secondary | The impact of art workshops and cognitive lectures for parents of children with solid tumors vs. liquid tumors by comparing the level of psychological resilience and coping ability in those parents. | From enrollment to the end of program at 3 months. | Using the Connor-Davidson Resilience Scale (CD-RISC) which defines resilience through several dimensions, each capturing a different psychological strength: hardiness, optimism, resourcefulness, and purpose/goal. Together, they measure how individuals adapt and thrive under stress. The scale consists of 25 items. Responses are given from the following options: Very high degree High degree Moderate degree Low degree Very low degree Each item is scored from 5 points down to 1 point. The highest possible score is 125 (25 items × 5 points). The lowest possible score is 25 (25 items × 1 point). High scores indicate strong resilience, while low scores indicate weak resilience. Results from parents of children with solid tumors and liquid tumors are compared to see the if there are any differences in the impact of these art workshops and cognitive lectures between the two populations. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07878078
GET https://conductscience.org/api/trials/v1/NCT07878078/registered